New Zealand markets closed

Poseida Therapeutics, Inc. (PSTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.9000+0.0200 (+0.69%)
At close: 04:00PM EDT
2.9000 0.00 (0.00%)
After hours: 04:02PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-108,857
-123,430
-64,002
-124,974
-129,775
-
Depreciation & amortisation
5,670
5,614
5,172
4,552
2,586
-
Deferred income taxes
-
-
-
-
-
0
Stock-based compensation
21,037
23,134
18,926
16,704
7,220
-
Change in working capital
24,080
14,081
13,715
20,168
5,623
-
Accounts receivable
-3,589
77
-9,088
0
-
-
Accounts payable
-491
1,038
-6,748
7,842
-4,171
-
Other working capital
-71,709
-95,233
-30,696
-105,177
-130,236
-
Other non-cash items
1,147
808
844
639
805
-
Net cash provided by operating activities
-69,297
-92,167
-26,772
-102,543
-113,328
-
Cash flows from investing activities
Investments in property, plant and equipment
-2,412
-3,066
-3,924
-2,634
-16,908
-
Purchases of investments
-237,536
-237,800
-294,422
0
-295,023
-
Sales/maturities of investments
307,500
280,000
95,000
225,000
107,500
-
Net cash used for investing activities
67,552
39,134
-203,334
222,384
-204,431
-
Cash flows from financing activities
Common stock issued
14,417
15,345
75,299
0
205,743
-
Other financing activities
-592
-494
-1,450
-
3,834
4,589
Net cash used provided by (used for) financing activities
14,898
16,127
105,159
2,518
313,941
-
Net change in cash
13,153
-36,906
-124,947
122,359
-3,818
-
Cash at beginning of period
40,144
81,378
206,325
83,966
87,784
-
Cash at end of period
53,297
44,472
81,378
206,325
83,966
-
Free cash flow
Operating cash flow
-69,297
-92,167
-26,772
-102,543
-113,328
-
Capital expenditure
-2,412
-3,066
-3,924
-2,634
-16,908
-
Free cash flow
-71,709
-95,233
-30,696
-105,177
-130,236
-